Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Wei-Yu KaoI-Wei ChangChi-Long ChenChien-Wei SuSheng Uei FangJui-Hsiang TangChun-Chao ChangYu-Jia ChangWeu Wang

Published in: Obesity surgery (2021)

We developed a simple, clinical scoring system incorporating Fibroscan and APRI to predict significant liver fibrosis in morbidly obese patients.

Keyphrases